Transforming patient outcomes through manufacturing and commercialization of groundbreaking cell and gene therapies

We’ve been manufacturing cutting edge cell and gene therapies for over 18 years

cell therapies is an Australian-based, globally-active commercial contract development and manufacturing company, specializing in cell therapy, gene therapy, regenerative medicine, and cellular immunotherapy products.

A leader in this groundbreaking field, our expert team and world-class facilities have been developing and manufacturing cutting edge treatments for cancer and rare diseases on behalf of local and international clients since 2003.

Explore our services

Cell Therapies has extensive experience in the development and commercialization of cell and gene therapies for the Australian and global markets.

Apheresis Management

Over 18 years’ experience managing apheresis collections under GMP quality oversight

Contract Manufacturing

Licensed GMP manufacturing and process development for clinical trials and commercial supply

Clinical Trial Support

Enabling global clinical trial establishment by assisting from trial design to regulatory submission

Consulting and Advisory

The expertise to advance your program from clinical trial through to commercial supply

Industry-leading GMP facility delivering cell and gene therapies from Australia to the world

cell therapies GMP facility is located in Melbourne, Australia, and has manufacturing licences for clinical and commercial supply from Australia’s regulatory agency, the Therapeutic Goods Administration (TGA). Our facility also complies with global regulatory standards for US (FDA), Europe (EMA), Japan (MHLW) and other jurisdictions.

Contact the Cell Therapies Team today

Call Cell Therapies on +61 3 8559 7310 to talk to our expert team or enter your details below and we will contact you to arrange a call at a time that suits you.

Our Partners and Affiliations

Latest News

Announcement from the Chair of the Cell Therapies Board

| News | No Comments
The Board of Directors of Cell Therapies Pty Ltd is delighted to announce that Ms. Michelle Burke has been appointed as a Non-Executive Director of Cell Therapies Pty Ltd. "Michelle has extensive Board and…

Protecting your cell therapy trial by building resilience in your supply chain

| News | No Comments
Supply chain complexity has always been a factor in healthcare. Drugs are often time- or temperature-sensitive, which make maintaining product quality a significant challenge. But the emergence of cell and…

The fast path to first-in-human cell therapy trials

| News | No Comments
The development of cell and gene therapies (CGT) holds enormous promise for treating many different diseases. The success of CAR-T therapies in treating blood cancers has seen exponential growth in…

Cell Therapies Pty Ltd facility accredited by the Ministry of Health, Labour and Welfare in Japan

| News | No Comments
Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the Asia Pacific region, is proud to announce that its proprietary facility has been accredited by…